Felix Hoffmann, Wilhelm Roehl, Hans Andersag and Walter Kikuth, Gerhard Domagk, Otto Bayer, Friedrich Bossert, Wulf Vater – researchers and scientists who made history. They were responsible for pioneering inventions that revolutionized medicine, chemistry and materials development: Aspirin™, Germanin™, Resochin™, sulfonamides and Adalat™.
We maintain a global network of research and development locations, where more than 15,000 scientists are employed. In 2016, we increased our research and development investment by 9.8 percent (Fx adj.) to €4.666 billion.
Innovation is a cornerstone of our mission “Science For A Better Life” and a core element of our strategy. We define innovations as new solutions that generate added value for our customers and society. Our activities focus on innovative products based on our strong research and development competencies. They are accompanied by process, service and business model innovation.
With our innovative solutions, we are responding to the global challenges in medical care and the need to safeguard an adequate food supply. Here we focus on three key elements: excellence in research and development, the application of groundbreaking technologies, and open innovation.